Functional profiling of circulating tumor cells with an integrated vortex capture and single-cell protease activity assay
- 17 September 2018
- journal article
- research article
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 115 (40) , 9986-9991
Abstract
Significance: The current paradigm in liquid biopsies focuses on circulating tumor cell (CTC) count and genomics to provide clinically actionable information. We push beyond current capabilities to introduce a functional assay that quantifies protease secretion from live CTCs with single-cell resolution. In this assay, an integrated microfluidic device captures CTCs from blood and washes and encapsulates them into nanoliter-scale droplets with fluorogenic substrates within minutes, maintaining physiologic conditions. Our data support the presence of outlier CTCs with high protease activity that may drive metastasis or immune evasion. We reveal an intriguing correlation between CTC protease activity and metastatic progression. Such functional liquid biopsy approaches provide avenues to understand the metastatic process and potential for companion diagnostics.Keywords
This publication has 33 references indexed in Scilit:
- Multiplexed Protease Activity Assay for Low-Volume Clinical Samples Using Droplet-Based Microfluidics and Its Application to EndometriosisJournal of the American Chemical Society, 2012
- Enhancing Protease Activity Assay in Droplet-Based Microfluidics Using a Biomolecule ConcentratorJournal of the American Chemical Society, 2011
- Matrix metalloproteinase‐9 cooperates with transcription factor Snail to induce epithelial–mesenchymal transitionCancer Science, 2011
- Circulating Tumor Cell Detection Predicts Early Metastatic Relapse After Neoadjuvant Chemotherapy in Large Operable and Locally Advanced Breast Cancer in a Phase II Randomized TrialClinical Cancer Research, 2008
- Tumor-derived matrix metalloproteinase-13 (MMP-13) correlates with poor prognosis of invasive breast cancerBMC Cancer, 2008
- Circulating Tumor Cell Number and Prognosis in Progressive Castration-Resistant Prostate CancerClinical Cancer Research, 2007
- Membrane type matrix metalloproteinases (MMPs) show differential expression in non-small cell lung cancer (NSCLC) compared to normal lung: Correlation of MMP-14 mRNA expression and proteolytic activityEuropean Journal of Cancer, 2007
- Platelets release active matrix metalloproteinase‐2 in vivo in humans at a site of vascular injury: lack of inhibition by aspirinBritish Journal of Haematology, 2007
- Circulating Tumor Cells: A Novel Prognostic Factor for Newly Diagnosed Metastatic Breast CancerJournal of Clinical Oncology, 2005
- New functions for the matrix metalloproteinases in cancer progressionNature Reviews Cancer, 2002